QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers

Abstract

Strong evidence exists for a central role of amyloid ß-protein (Aß) oligomers in the pathogenesis of Alzheimer`s disease. We have developed a fast, reliable and robust in vitro assay, termed QIAD, to quantify the effect of any compound on the Aß aggregate size distribution. Applying QIAD, we studied the effect of homotaurine, scyllo-inositol, EGCG, the benzofuran derivative KMS88009, ZAß3W, the D-enantiomeric peptide D3 and its tandem version D3D3 on Aß aggregation. The predictive power of the assay for in vivo efficacy is demonstrated by comparing the oligomer elimination efficiency of D3 and D3D3 with their treatment effects in animal models of Alzheimer´s disease.

mehr

Mehr zum Titel

Titel QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers
Medien Scientific Reports
Band 2015 / 5
Verfasser Oleksandr Brener, Tina Dunkelmann, Lothar Gremer, Thomas van Groen, Ewa A. Mirecka, Inga Kadish, Antje Willuweit, Janine Kutzsche, Dagmar Jürgens, Stephan Rudolph, Markus Tusche, Patrick Bongen, Jörg Pietruszka, Filipp Oesterhelt, Karl-Josef Langen, Hans-Ulrich Demuth, Arnold Janssen, Wolfgang Hoyer, Prof. Dr. Susanne Funke, Luitgard Nagel-Steger, Dieter Willbold
Seiten 13222
Veröffentlichungsdatum 23.09.2015
Zitation Brener, Oleksandr; Dunkelmann, Tina; Gremer, Lothar; van Groen, Thomas; Mirecka, Ewa A.; Kadish, Inga; Willuweit, Antje; Kutzsche, Janine; Jürgens, Dagmar; Rudolph, Stephan; Tusche, Markus; Bongen, Patrick; Pietruszka, Jörg; Oesterhelt, Filipp; Langen, Karl-Josef; Demuth, Hans-Ulrich; Janssen, Arnold; Hoyer, Wolfgang; Funke, Susanne A.; Nagel-Steger, Luitgard; Willbold, Dieter (2015): QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers. Scientific Reports 2015 / 5, 13222. DOI: 10.1038/srep13222